TSP1292-CMap - NLT_B: Toxicogenomic signatures after exposure to oxaliplatin


TSA9810-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin


TSA9820-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin


TSF13836-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 49.99 µM


1 subfactor(s)
TSF13837-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 24.98 µM


1 subfactor(s)
TSF13838-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 12.46 µM


1 subfactor(s)
TSF13839-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 6.24 µM


1 subfactor(s)
TSF13840-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 3.12 µM


1 subfactor(s)
TSF13841-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 1.6 µM


1 subfactor(s)
TSF13842-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.8 µM


1 subfactor(s)
TSF13843-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.39 µM


1 subfactor(s)
TSF13844-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.2 µM


1 subfactor(s)
TSF13845-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.1 µM


1 subfactor(s)
TSF13846-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.05 µM


1 subfactor(s)
TSF13946-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 49.99 µM


1 subfactor(s)
TSF13947-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 24.98 µM


1 subfactor(s)
TSF13948-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 12.46 µM


1 subfactor(s)
TSF13949-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 6.24 µM


1 subfactor(s)
TSF13950-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 3.12 µM


1 subfactor(s)
TSF13951-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 1.6 µM


1 subfactor(s)
TSF13952-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.8 µM


1 subfactor(s)
TSF13953-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.39 µM


1 subfactor(s)
TSF13954-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.2 µM


1 subfactor(s)
TSF13955-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.1 µM


1 subfactor(s)
TSF13956-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.05 µM


1 subfactor(s)
TSS13839-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 49.99 µM


TSS13840-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 24.98 µM


TSS13841-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 12.46 µM


TSS13842-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 6.24 µM


TSS13843-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 3.12 µM


TSS13844-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 1.6 µM


TSS13845-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.8 µM


TSS13846-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.39 µM


TSS13847-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.2 µM


TSS13848-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.1 µM


TSS13849-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.05 µM


TSS13949-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 49.99 µM


TSS13950-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 24.98 µM


TSS13951-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 12.46 µM


TSS13952-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 6.24 µM


TSS13953-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 3.12 µM


TSS13954-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 1.6 µM


TSS13955-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.8 µM


TSS13956-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.39 µM


TSS13957-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.2 µM


TSS13958-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.1 µM


TSS13959-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.05 µM



TSP1292 - CMap - NLT_B: Toxicogenomic signatures after exposure to oxaliplatin Public


https://clue.io/data/NLT#NLT_B

Experimental design


No experimental design provided

Results


No results provided